Form 8-K Vera Therapeutics, Inc. For: Jan 29

Go back to Form 8-K Vera Therapeutics, Inc. For: Jan 29

Vera Therapeutics (VERA) Terminates ATM Offering

January 29, 2024 6:28 AM EST

Effective January 29, 2024, Vera Therapeutics Inc. (NASDAQ: VERA) suspended and terminated the prospectus (the ATM Prospectus) related to the sale of its Class A common stock, $0.001 par value per share (the Common Stock) in an at-the-market offering pursuant to the terms of the Sales Agreement, dated June 3, 2022, by and between the Company and Cowen and Company, LLC (the Sales Agreement). As a result, the Company will not make any sales of its Common... More